artificial intelligence
Sebia, Metafora Biosystems Partner to Develop IVD Tests
Metafora's single-cell diagnostic platform uses artificial intelligence to detect cellular metabolism anomalies.
Sophia Genetics Q2 Revenue Grows 72 Percent
In its first quarterly report as a public company, Sophia reported a net loss of $18.4 million, in part due to higher expenses related to its July IPO.
Skin Cancer Dx Firm Speclipse Raises Nearly $8M to Expand Business
The South Korean company plans to use the funding to develop its laser spectroscopy and artificial intelligence technologies for blood analysis.
The digital pathology firm is working to further develop its diagnostic capabilities and broaden its menu of algorithms for different diseases.
Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships
The stock opened at $18 per share, valuing the Switzerland- and Boston-based bioinformatics company at $1.14 billion.